BioToxTech Co Ltd recorded three insider trading transactions over the past ninety days, all involving Representative Director Kang Jong Koo. These acquisitions totaled approximately 8.2 million KRW in net buying. The stock currently trades near its fifty-two-week low, reflecting a 3.7% decline during this period, while no recent earnings report has been released.